RBC Capital Downgrades Insmed (INSM) to Sector Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $95.06 +1.08%
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Rating Summary:
31 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Join SI Premium – FREE
RBC Capital downgraded Insmed (NASDAQ: INSM) from Outperform to Sector Perform, price target cut from $15 to $10.00.
For more ratings news on Insmed click here and for the rating history of Insmed click here.
Shares of Insmed closed at $11.35 yesterday.
For more ratings news on Insmed click here and for the rating history of Insmed click here.
Shares of Insmed closed at $11.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insmed (INSM) PT Lowered to $213 at Morgan Stanley
- William Blair Downgrades Builders FirstSource (BLDR) to Market Perform
- Aviva Plc (AV/:LN) (AIVAF) PT Raised to GBP7.90 at RBC Capital
Create E-mail Alert Related Categories
DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
